CLSA Events

CEO and CFO Roundtables World of Incentives: Non-Equity: What’s Your Plan? | Part Two

This two-part Executive Series Roundtable will discuss compensation package design issues: industry veterans will share their experience with both equity and non-equity components, they try to answer the single most important question: how do you design an incentive program that helps retain top talent?

Non-Equity: What’s Your Plan? | Part Two

With the economy in recession, cash is king. Non-equity incentive compensation can represent a large part of pay for some executives. Discuss with experienced CEOs and industry experts:

  • What tools are tried and true: What are the tools of the future?
  • How do non-biotech companies design their incentive plans?
  • How do you sell non-equity incentive plans to employees?


Laura Berezin
Partner, Hogan Lovells US LLP


Steve Engle
Former Chairman and CEO of XOMA

Mary Haak-Frendscho, PhD
President and Chief Scientific Officer, Takeda San Francisco (TSF)

Igor Gonda, PhD
President and Chief Executive Officer, Aradigm

Diana M. Petty, SPHR
VP Human Resources & Administration, Metabolex, Inc.

Thomas J. Schall, Ph.D.
President and CEO, ChemoCentryx, Inc.

William Waddill
Senior Vice President and CFO, OncoMed Pharmaceuticals Inc.

Matt Ward
National Practice Leader, Compensation, Barney & Barney LLC

What: CEO and CFO Roundtables
World of Incentives: Non-Equity: What’s Your Plan? | Part Two
When: October 11, 2011
5:30pm– 7:30pm
Where: OncoMed Pharmaceuticals, Inc.
800 Chesapeake Dr.
Redwood City, CA 94063-4748
Parking: Complimentary On-Site
Attire: Business attire suggested
Attendance: Open to C-Suite Executives of Life Sciences Companies Only.
Cost: BayBio Members – FREE
Non-Members – $75.00